- Report
- August 2025
- 184 Pages
Global
From €3120EUR$3,545USD£2,700GBP
€3467EUR$3,939USD£3,000GBP
- Report
- August 2025
- 183 Pages
Global
From €3120EUR$3,545USD£2,700GBP
€3467EUR$3,939USD£3,000GBP
- Report
- February 2026
- 200 Pages
Global
From €2632EUR$2,990USD£2,277GBP
- Report
- February 2026
- 250 Pages
Global
From €3952EUR$4,490USD£3,420GBP
- Report
- November 2025
- 200 Pages
Global
From €6997EUR$7,950USD£6,055GBP
- Report
- March 2026
- 131 Pages
Global
From €3500EUR$4,260USD£3,135GBP
- Report
- July 2025
- 101 Pages
Global
From €3500EUR$4,260USD£3,135GBP
- Report
- May 2024
- 129 Pages
Global
From €3520EUR$3,999USD£3,046GBP
- Report
- August 2023
- 145 Pages
Global
From €2773EUR$3,150USD£2,399GBP
- Report
- November 2023
- 30 Pages
United States
From €2420EUR$2,750USD£2,094GBP
- Report
- May 2024
- 136 Pages
Global
From €3520EUR$3,999USD£3,046GBP
- Report
- July 2024
- 100 Pages
Global
From €3301EUR$3,750USD£2,856GBP
- Report
- March 2024
- 303 Pages
Global
From €6997EUR$7,950USD£6,055GBP
- Report
- March 2021
- 149 Pages
Global
From €6117EUR$6,950USD£5,293GBP
- Report
- September 2022
- 392 Pages
Global
From €3169EUR$3,600USD£2,742GBP

Loteprednol is a topical corticosteroid used to treat a variety of ocular disorders, including allergic conjunctivitis, vernal keratoconjunctivitis, and post-operative inflammation. It is available in both ophthalmic suspension and ointment forms. Loteprednol is a synthetic corticosteroid that works by reducing inflammation and suppressing the immune system. It is used to reduce the symptoms of eye inflammation, such as redness, itching, and swelling.
Loteprednol is a popular choice for treating ocular disorders due to its low risk of side effects and its ability to reduce inflammation quickly. It is also used to treat dry eye syndrome, a condition that can cause discomfort and blurred vision. Loteprednol is available in both generic and brand-name forms.
The Loteprednol market is a competitive one, with many companies offering products for the treatment of ocular disorders. Some of the companies in the market include Allergan, Bausch + Lomb, Merck, Novartis, and Pfizer. Show Less Read more